Cancer convergence最新文献

{"title":"Detecting heterogeneity in and between breast cancer cell lines.","authors":"Yang Shen,&nbsp;B U Sebastian Schmidt,&nbsp;Hans Kubitschke,&nbsp;Erik W Morawetz,&nbsp;Benjamin Wolf,&nbsp;Josef A Käs,&nbsp;Wolfgang Losert","doi":"10.1186/s41236-020-0010-1","DOIUrl":"https://doi.org/10.1186/s41236-020-0010-1","url":null,"abstract":"<p><strong>Background: </strong>Cellular heterogeneity in tumor cells is a well-established phenomenon. Genetic and phenotypic cell-to-cell variability have been observed in numerous studies both within the same type of cancer cells and across different types of cancers. Another known fact for metastatic tumor cells is that they tend to be softer than their normal or non-metastatic counterparts. However, the heterogeneity of mechanical properties in tumor cells are not widely studied.</p><p><strong>Results: </strong>Here we analyzed single-cell optical stretcher data with machine learning algorithms on three different breast tumor cell lines and show that similar heterogeneity can also be seen in mechanical properties of cells both within and between breast tumor cell lines. We identified two clusters within MDA-MB-231 cells, with cells in one cluster being softer than in the other. In addition, we show that MDA-MB-231 cells and MDA-MB-436 cells which are both epithelial breast cancer cell lines with a mesenchymal-like phenotype derived from metastatic cancers are mechanically more different from each other than from non-malignant epithelial MCF-10A cells.</p><p><strong>Conclusion: </strong>Since stiffness of tumor cells can be an indicator of metastatic potential, this result suggests that metastatic abilities could vary within the same monoclonal tumor cell line.</p>","PeriodicalId":92184,"journal":{"name":"Cancer convergence","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s41236-020-0010-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37671083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cancer dormancy and criticality from a game theory perspective.","authors":"Amy Wu, David Liao, Vlamimir Kirilin, Ke-Chih Lin, Gonzalo Torga, Junle Qu, Liyu Liu, James C Sturm, Kenneth Pienta, Robert Austin","doi":"10.1186/s41236-018-0008-0","DOIUrl":"10.1186/s41236-018-0008-0","url":null,"abstract":"<p><strong>Background: </strong>The physics of cancer dormancy, the time between initial cancer treatment and re-emergence after a protracted period, is a puzzle. Cancer cells interact with host cells via complex, non-linear population dynamics, which can lead to very non-intuitive but perhaps deterministic and understandable progression dynamics of cancer and dormancy.</p><p><strong>Results: </strong>We explore here the dynamics of host-cancer cell populations in the presence of (1) payoffs gradients and (2) perturbations due to cell migration.</p><p><strong>Conclusions: </strong>We determine to what extent the time-dependence of the populations can be quantitively understood in spite of the underlying complexity of the individual agents and model the phenomena of dormancy.</p>","PeriodicalId":92184,"journal":{"name":"Cancer convergence","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876693/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35984032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Non-randomness of the anatomical distribution of tumors.","authors":"Clare Yu,&nbsp;James Kameron Mitchell","doi":"10.1186/s41236-017-0006-7","DOIUrl":"https://doi.org/10.1186/s41236-017-0006-7","url":null,"abstract":"<p><strong>Background: </strong>Why does a tumor start where it does within an organ? Location is traditionally viewed as a random event, yet the statistics of the location of tumors argues against this being a random occurrence. There are numerous examples including that of breast cancer. More than half of invasive breast cancer tumors start in the upper outer quadrant of the breast near the armpit, even though it is estimated that only 35 to 40% of breast tissue is in this quadrant. This suggests that there is an unknown microenvironmental factor that significantly increases the risk of cancer in a spatial manner and that is not solely due to genes or toxins. We hypothesize that tumors are more prone to form in healthy tissue at microvascular 'hot spots' where there is a high local concentration of microvessels providing an increased blood flow that ensures an ample supply of oxygen, nutrients, and receptors for growth factors that promote the generation of new blood vessels.</p><p><strong>Results: </strong>To show the plausibility of our hypothesis, we calculated the fractional probability that there is at least one microvascular hot spot in each region of the breast assuming a Poisson distribution of microvessels in two-dimensional cross sections of breast tissue. We modulated the microvessel density in various regions of the breast according to the total hemoglobin concentration measured by near infrared diffuse optical spectroscopy in different regions of the breast. Defining a hot spot to be a circle of radius 200 μm with at least 5 microvessels, and using a previously measured mean microvessel density of 1 microvessel/mm², we find good agreement of the fractional probability of at least one hot spot in different regions of the breast with the observed invasive tumor occurrence. However, there is no reason to believe that the microvascular distribution obeys a Poisson distribution.</p><p><strong>Conclusions: </strong>The spatial location of a tumor in an organ is not entirely random, indicating an unknown risk factor. Much work needs to be done to understand why a tumor occurs where it does.</p>","PeriodicalId":92184,"journal":{"name":"Cancer convergence","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s41236-017-0006-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35982445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Distinguishing mechanisms underlying EMT tristability.","authors":"Dongya Jia,&nbsp;Mohit Kumar Jolly,&nbsp;Satyendra C Tripathi,&nbsp;Petra Den Hollander,&nbsp;Bin Huang,&nbsp;Mingyang Lu,&nbsp;Muge Celiktas,&nbsp;Esmeralda Ramirez-Peña,&nbsp;Eshel Ben-Jacob,&nbsp;José N Onuchic,&nbsp;Samir M Hanash,&nbsp;Sendurai A Mani,&nbsp;Herbert Levine","doi":"10.1186/s41236-017-0005-8","DOIUrl":"https://doi.org/10.1186/s41236-017-0005-8","url":null,"abstract":"<p><strong>Background: </strong>The Epithelial-Mesenchymal Transition (EMT) endows epithelial-looking cells with enhanced migratory ability during embryonic development and tissue repair. EMT can also be co-opted by cancer cells to acquire metastatic potential and drug-resistance. Recent research has argued that epithelial (E) cells can undergo either a partial EMT to attain a hybrid epithelial/mesenchymal (E/M) phenotype that typically displays collective migration, or a complete EMT to adopt a mesenchymal (M) phenotype that shows individual migration. The core EMT regulatory network - miR-34/SNAIL/miR-200/ZEB1 - has been identified by various studies, but how this network regulates the transitions among the E, E/M, and M phenotypes remains controversial. Two major mathematical models - ternary chimera switch (TCS) and cascading bistable switches (CBS) - that both focus on the miR-34/SNAIL/miR-200/ZEB1 network, have been proposed to elucidate the EMT dynamics, but a detailed analysis of how well either or both of these two models can capture recent experimental observations about EMT dynamics remains to be done.</p><p><strong>Results: </strong>Here, via an integrated experimental and theoretical approach, we first show that both these two models can be used to understand the two-step transition of EMT - E→E/M→M, the different responses of SNAIL and ZEB1 to exogenous TGF-β and the irreversibility of complete EMT. Next, we present new experimental results that tend to discriminate between these two models. We show that ZEB1 is present at intermediate levels in the hybrid E/M H1975 cells, and that in HMLE cells, overexpression of SNAIL is not sufficient to initiate EMT in the absence of ZEB1 and FOXC2.</p><p><strong>Conclusions: </strong>These experimental results argue in favor of the TCS model proposing that miR-200/ZEB1 behaves as a three-way decision-making switch enabling transitions among the E, hybrid E/M and M phenotypes.</p>","PeriodicalId":92184,"journal":{"name":"Cancer convergence","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s41236-017-0005-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35982449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A network modeling approach to elucidate drug resistance mechanisms and predict combinatorial drug treatments in breast cancer.","authors":"Jorge Gómez Tejeda Zañudo, Maurizio Scaltriti, Réka Albert","doi":"10.1186/s41236-017-0007-6","DOIUrl":"10.1186/s41236-017-0007-6","url":null,"abstract":"<p><strong>Background: </strong>Mechanistic models of within-cell signal transduction networks can explain how these networks integrate internal and external inputs to give rise to the appropriate cellular response. These models can be fruitfully used in cancer cells, whose aberrant decision-making regarding their survival or death, proliferation or quiescence can be connected to errors in the state of nodes or edges of the signal transduction network.</p><p><strong>Results: </strong>Here we present a comprehensive network, and discrete dynamic model, of signal transduction in ER+ breast cancer based on the literature of ER+, HER2+, and PIK3CA-mutant breast cancers. The network model recapitulates known resistance mechanisms to PI3K inhibitors and suggests other possibilities for resistance. The model also reveals known and novel combinatorial interventions that are more effective than PI3K inhibition alone.</p><p><strong>Conclusions: </strong>The use of a logic-based, discrete dynamic model enables the identification of results that are mainly due to the organization of the signaling network, and those that also depend on the kinetics of individual events. Network-based models such as this will play an increasing role in the rational design of high-order therapeutic combinations.</p>","PeriodicalId":92184,"journal":{"name":"Cancer convergence","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876695/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35982447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Probing three-dimensional collective cancer invasion with DIGME.","authors":"Amani A Alobaidi, Bo Sun","doi":"10.1186/s41236-017-0004-9","DOIUrl":"10.1186/s41236-017-0004-9","url":null,"abstract":"<p><strong>Background: </strong>Multicellular pattern formation plays an important role in developmental biology, cancer metastasis and wound healing. While many physical factors have been shown to regulate these multicellular processes, the role of ECM micro-to-meso scale geometry has been poorly understood in 3D collective cancer invasion.</p><p><strong>Results: </strong>We have developed a mechanical-based strategy, Diskoid In Geometrically Micropatterned ECM (DIGME). DIGME allows easy engineering of the shape of 3D tissue organoid, the mesoscale ECM heterogeneity, and the fiber alignment of collagen-based ECM all at the same time. We have employed DIGME to study the 3D invasion of MDA-MB-231 diskoids in engineered collagen matrix. We find that the collective cancer invasion is closely regulated by the micro-to-meso scale geometry of the ECM.</p><p><strong>Conclusions: </strong>We conclude that DIGME provides a simple yet powerful tool to probe 3D dynamics of tissue organoids in physically patterned microenvironments.</p>","PeriodicalId":92184,"journal":{"name":"Cancer convergence","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876692/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35984030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Introducing cancer convergence.","authors":"Krastan B Blagoev,&nbsp;David T Ting,&nbsp;Herbert Levine,&nbsp;Yvonne Saenger,&nbsp;Thea D Tlsty,&nbsp;Bo Sun","doi":"10.1186/s41236-017-0003-x","DOIUrl":"https://doi.org/10.1186/s41236-017-0003-x","url":null,"abstract":"","PeriodicalId":92184,"journal":{"name":"Cancer convergence","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s41236-017-0003-x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35984031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}